TrueVision Completes $146 Million Sale to Alcon

Represented TrueVision, a developer of a high-definition visualization system designed to offer digital visualization and augmented reality guidance for microsurgery, in its $146 million sale to Geneva-based Alcon (SWC: ALC). When negotiations met an impasse with the buyer, our team stepped in to convince the buyer that eliminating a Chinese distributor/joint venture was acceptable and to interpret and resolve a difficult problem with shareholders in Germany that the existing tax and M&A attorney team was unable to articulate. We were able to close the deal in favor of all parties.